Speeches & presentations

Search through our archive of speeches and presentations from conferences and events.

Filter by

  • Deirdre Connelly, employee

    North Carolina CEO Forum

    Deirdre Connelly, President, North America Pharmaceuticals, spoke at the North Carolina CEO Forum about the importance of curiosity, vision, flexibility, and risk-taking to create a high-performing, innovative, and sustainable business.

  • David Redfern

    Goldman Sachs 34th Annual Global Healthcare Conference, California USA

    David Redfern, Chief Strategy Officer, gave a fireside chat on GSK’s business strategy and addressed questions in front of a large group of US investors at the Goldman Sachs Conference in California on Wednesday 12 June 2013.

    Webcast
  • Investor Event at ATS 2013, Philadelphia

    Darrell Baker, Senior Vice President, Head of Global Respiratory Franchise hosted an investor event comprising a short presentation and Q&A session based on data presented at ATS.

  • Leerink Swann Healthcare Conference

    Simon Dingemans, Chief Financial Officer, addressed questions in front of a large group of US investors at the Leerink Swann Global Healthcare Conference on Wednesday, February 13 in New York.  Simon provided an overview of GSK’s 2012 full year results and outlook for the future.

    Webcast
  • Dr Patrick Vallance

    Late-stage pipeline review - Patrick Vallance

    Patrick Vallance, President, Pharmaceutical R&D gave a presentation at the 31st Annual JP Morgan Healthcare Conference in San Francisco. Patrick provided a review of the progress being made on the late stage pipeline.

  • Dr Moncef Slaoui

    Late-stage pipeline review - Sir Andrew Witty, Dr Moncef Slaoui, and Dr Patrick Vallance

    Sir Andrew Witty (CEO), Dr Moncef Slaoui (Chairman of R&D) and Dr Patrick Vallance (President of Pharmaceutical R&D) together with senior R&D leaders hosted a seminar focusing on GSK’s late stage pipeline. The event brought together the progress made in 2012, as Phase III programmes for a significant number of potential new drugs have concluded. It also provided an overview of our progress on our returns driven strategy in R&D and the sustainability of our pipeline.

  • Deidre Connelly, Member of our Corporate Executive team, Talking

    Annual Pharmaceutical Regulatory and Compliance Congress

    Deidre Connelly, President North America Pharmaceuticals, spoke at the 13th Annual Pharmaceutical Regulatory and Compliance Congress about how we conduct our business.

  • Investor Meeting at ESMO, Vienna

    Dr Paolo Paoletti, President of GSK Oncology, hosted an investor event in conjunction with data presented at the European Society for Medical Oncology.

  • David Redfern

    Investor Meeting at IAC, Washington

    ViiV Healthcare Chairman David Redfern, CEO Dominique Limet and Chief Scientific and Medical Officer, John Pottage, hosted an investor event at the International AIDS Conference (IAC).

  • Investor Meeting at ADA, Philadelphia

    Dr Carlo Russo, Senior Vice President and Head of Albiglutide Development hosted an investor event in conjunction with data presented at the American Diabetes Association meeting.

  • Investor Meeting at ASCO, Chicago

    Paolo Paoletti, President of GSK Oncology, hosted an investor event in conjunction with data presented at the American Society of Clinical Oncology (ASCO) meeting.

    Webcast
  • Deidre Connelly, Member of our Corporate Executive team, Talking

    World Affairs Council, Philadelphia

    Deirdre Connelly, President, North America Pharmaceuticals, gave a speech at the World Affairs Council (WAC) in Philadelphia about how the challenges and opportunities facing the pharmaceutical business.

  • Dr Moncef Slaoui

    R&D Seminar

    Moncef Slaoui, Chairman of Research & Development and Patrick Vallance, President, Pharmaceuticals R&D, presented a live webcast - Capital Allocation in R&D and a DPU Deep Dive.

  • Deidre Connelly, Member of our Corporate Executive team, Talking

    PharmEHR Summit, Philadelphia

    Deirdre Connelly, President, North America Pharmaceuticals, gave a speech at PharmEHR Summit in Philadelphia about how GSK sees healthcare evolving and how electronic health records fit into that shifting landscape.

  • Simon Dingemans, CFO, GSK

    Annual JP Morgan Healthcare Conference

    Simon Dingemans, Chief Financial Officer, gave a presentation at the 30th Annual JP Morgan Healthcare Conference in San Francisco.  Simon provided an overview of the progress being made in implementing GSK’s strategy.

  • Core Earnings Reporting

    Simon Dingemans, Chief Financial Officer discusses the methodology GSK will use for its core earnings reporting to begin with effect from Q1 2012.

  • Abbas Hussain

    Credit Suisse Healthcare Conference, Hong Kong

    Abbas Hussain, President, Emerging Markets & Asia Pacific gave a presentation at the Credit Suisse Asia Healthcare Conference in Hong Kong.  Abbas provided an overview of GSK's emerging markets strategy.

  • Bernstein Conference, New York

    Adrian Rawcliffe, SVP Finance North American Pharmaceuticals, presented at the Bernstein Pharma Conference: “Pharmaceutical R&D Productivity: Diagnosing the Problem & Searching for Solutions” in New York City. The conference was attended by over 100 investors. Ad discussed GSK’s R&D Strategy and its Focus on Return on Investment.

  • Citi’s Seminar in London on Vaccines in Emerging Markets

    Martin Andrews, SVP – Global Vaccines Centre of Excellence, GSK Biologicals, gave a presentation on GSK’s vaccines business at Citi’s Seminar in London on Vaccines in Emerging Markets.

  • Sir Andrew Witty

    Andrew Witty presents to the US State Department

    GSK CEO Andrew Witty presented at the United States Department of State symposium, “The Role of Innovation in Addressing Global Health”. In his address, which was convened to discuss advances and ways of working together to overcome diseases of the developing world, Andrew expanded upon GlaxoSmithKline’s commitments in this area.

  1. 1
  2. 2
  3. 3
  4. 4